Sherlock™ CRISPR SARS-CoV-2
The Sherlock™ CRISPR SARS-CoV-2 kit is the first FDA authorized CRISPR-based EUA diagnostic test. The kit is intended for the qualitative detection of nucleic acid from SARS-CoV-2 in upper respiratory tract and bronchoalveolar lavage samples from individuals suspected of COVID-19 by their healthcare provider. This kit provides specific and sensitive identification of SARS-CoV-2.Order Here View our Webinar
Faster than PCR; approximately 1 hour reaction time
Add hundreds of tests per day to current lab volume
100% specificity and sensitivity in EUA clinical evaluation
Minimal footprint; uses standard laboratory equipment and a microplate reader
CRISPR SHERLOCK technology, proven highly sensitive with an LoD of 6.75 cp/uL VTM
- This test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens
- This test has not been FDA cleared or approved
- This test has been authorized by FDA under an EUA for use by authorized laboratories
- This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
This product is covered by one or more patents, trademarks and/or copyrights owned or controlled by Sherlock Biosciences, Inc (“Sherlock”) and its partners.
While Sherlock develops and validates its products for various applications, the use of this product may require the buyer to obtain additional third-party intellectual property rights for certain applications.
For more information about commercial rights, please contact Sherlock email@example.com.
This product is intended for non-commercial use solely in compliance with the product label, instructions for use, and the terms of sale. Resale is strictly forbidden.
Products provided by Sherlock are patented by Sherlock, or otherwise licensed, under U.S.Patents Nos. U.S. 6,410,278; 6,974,670; 7,494,790; 8,017,357; 7,374,913; 7,851,186; 7, 846, 695, 10, 266, 886; 10, 266, 887; and 9,790,490including all foreign counterparts thereof. This pageis intended to serve as notice under 35 U.S.C. § 287(a).
The purchase of this product conveys to the purchaser the limited, non-exclusive, non-transferable right to use the purchased product for non-commercial purposes only, to perform, in accordance with the product label, instructions for use, and the terms of sale:
(a) Loop-mediated isothermal amplification (“LAMP”), a patented technology belonging toEiken Chemical Co., Ltd.; and
(b) Specific High Sensitivity Enzymatic Reporter unLOCKing(“SHERLOCK”), a patented technology belonging to the Broad Institute, Inc..
Any use other than as expressly permitted in the product label, instructions for use, and the terms of sale may require a license from Eiken Chemical Co., Ltd., Sherlock Biosciences, Inc. and/or the Broad Institute, Inc.